Malaria vaccines are an area of intensive research. Emergence of artemisinin and multi-drug resistant strains of especially P. falciparum are driving research. Current approaches are focusing on recombinant protein and attenuated whole organism vaccines. Various vaccines have reached the state of clinical trials; most demonstrated insufficient immunogenicity. There is no practical or effective vaccine that has been introduced into clinical practice.
--------------------------------------------------------------
First malaria vaccine given green light by European regulators
European Medicines Agency recommends RTS,S, or Mosquirix, developed by GSK and backed by Gates Foundation, for use in young children in Africa---------------------------------------------------------------
https://en.wikipedia.org/wiki/Malaria_vaccine
http://www.theguardian.com/society/2015/jul/24/first-malaria-vaccine-given-green-light-by-european-regulators
Geen opmerkingen:
Een reactie posten